243 related articles for article (PubMed ID: 17207900)
1. The dilemma of approving antidotes.
Steffen C
Toxicology; 2007 Apr; 233(1-3):13-9. PubMed ID: 17207900
[TBL] [Abstract][Full Text] [Related]
2. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
3. Ethical dilemmas encountered during clinical drug trials.
Daicos GK
Hum Health Care; 2001; 1(2):E9. PubMed ID: 14986633
[TBL] [Abstract][Full Text] [Related]
4. Clinical and institutional aspects of antidote therapy in Russia.
Ostapenko YN; Luzhnikov EA; Nechiporenko SP; Petrov AN
Przegl Lek; 2001; 58(4):290-2. PubMed ID: 11450355
[TBL] [Abstract][Full Text] [Related]
5. Failure to report and provide commentary on research ethics board approval and informed consent in medical journals.
Finlay KA; Fernandez CV
J Med Ethics; 2008 Oct; 34(10):761-4. PubMed ID: 18827111
[TBL] [Abstract][Full Text] [Related]
6. Radiation information and informed consent for clinical trials.
Caon M
J Radiol Prot; 2008 Sep; 28(3):415-22. PubMed ID: 18714137
[TBL] [Abstract][Full Text] [Related]
7. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
8. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
9. Development of medicines for children in Europe: ethical implications.
Saint Raymond A; Brasseur D
Paediatr Respir Rev; 2005 Mar; 6(1):45-51. PubMed ID: 15698816
[TBL] [Abstract][Full Text] [Related]
10. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
11. Current views on antidotal therapy in managing cases of poisoning and overdose.
Pillay VV
J Assoc Physicians India; 2008 Nov; 56():881-92. PubMed ID: 19263688
[TBL] [Abstract][Full Text] [Related]
12. European survey on ethical and legal framework of clinical trials in paediatrics: results and perspectives.
Altavilla A; Giaquinto C; Ceci A
J Int Bioethique; 2008 Sep; 19(3):17-48, 121-2. PubMed ID: 19244940
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antidotes: activities of the International Programme on Chemical Safety.
Pronczuk de Garbino J; Haines JA; Jacobsen D; Meredith T
J Toxicol Clin Toxicol; 1997; 35(4):333-43. PubMed ID: 9204092
[TBL] [Abstract][Full Text] [Related]
14. Swine models in the design of more effective medical countermeasures against organophosphorus poisoning.
Dorandeu F; Mikler JR; Thiermann H; Tenn C; Davidson C; Sawyer TW; Lallement G; Worek F
Toxicology; 2007 Apr; 233(1-3):128-44. PubMed ID: 17092624
[TBL] [Abstract][Full Text] [Related]
15. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs?
Land WG; Gutmann T; Daar AS
Acta Chir Belg; 2008; 108(1):73-82. PubMed ID: 18411578
[TBL] [Abstract][Full Text] [Related]
16. The approach to the patient with an unknown overdose.
Erickson TB; Thompson TM; Lu JJ
Emerg Med Clin North Am; 2007 May; 25(2):249-81; abstract vii. PubMed ID: 17482020
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trials in developing countries: who should define ethics?].
Béréterbide F; Hirsch F
Bull Soc Pathol Exot; 2008 Apr; 101(2):102-5. PubMed ID: 18543701
[TBL] [Abstract][Full Text] [Related]
18. Hydroxocobalamin for acute cyanide poisoning: new data from preclinical and clinical studies; new results from the prehospital emergency setting.
Dart RC
Clin Toxicol (Phila); 2006; 44 Suppl 1():1-3. PubMed ID: 16990188
[No Abstract] [Full Text] [Related]
19. Development of antidotes: problems and strategies.
Szinicz L; Worek F; Thiermann H; Kehe K; Eckert S; Eyer P
Toxicology; 2007 Apr; 233(1-3):23-30. PubMed ID: 16949190
[TBL] [Abstract][Full Text] [Related]
20. [Clinical drug research from medical ethics and legal perspectives].
Ornek Büken N; Büken E
Turk Psikiyatri Derg; 2003; 14(4):289-99. PubMed ID: 14704931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
